NVRO

Nevro (NVRO)

Nevro Corp

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:NVRO

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/31	06 : 11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:NVRO	Nevro Corp
2024/05/31	06 : 09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:NVRO	Nevro Corp
2024/05/31	06 : 08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:NVRO	Nevro Corp
2024/05/30	05 : 21	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:NVRO	Nevro Corp
2024/05/29	07 : 58	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:NVRO	Nevro Corp
2024/05/29	07 : 56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:NVRO	Nevro Corp
2024/05/29	07 : 55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:NVRO	Nevro Corp
2024/05/25	05 : 15	PR Newswire (US)	Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08	NYSE:NVRO	Nevro Corp
2024/05/18	05 : 40	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NYSE:NVRO	Nevro Corp
2024/05/10	05 : 52	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:NVRO	Nevro Corp
2024/05/10	05 : 05	PR Newswire (US)	Nevro to Present at BofA Securities 2024 Healthcare Conference	NYSE:NVRO	Nevro Corp
2024/05/08	05 : 56	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NYSE:NVRO	Nevro Corp
2024/05/08	05 : 11	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:NVRO	Nevro Corp
2024/05/08	05 : 05	PR Newswire (US)	Nevro Reports First-Quarter 2024 Financial Results	NYSE:NVRO	Nevro Corp
2024/04/17	21 : 30	PR Newswire (US)	Nevro to Report First-Quarter 2024 Financial Results and Host Earnings Conference Call on May 7, 2024	NYSE:NVRO	Nevro Corp
2024/03/12	05 : 53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:NVRO	Nevro Corp
2024/03/12	05 : 52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:NVRO	Nevro Corp
2024/03/12	05 : 51	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:NVRO	Nevro Corp
2024/03/12	05 : 50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:NVRO	Nevro Corp
2024/03/12	05 : 49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:NVRO	Nevro Corp
2024/03/07	08 : 25	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:NVRO	Nevro Corp
2024/03/06	06 : 18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:NVRO	Nevro Corp
2024/03/06	06 : 16	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:NVRO	Nevro Corp
2024/03/06	06 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:NVRO	Nevro Corp
2024/03/02	07 : 56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:NVRO	Nevro Corp
2024/03/02	07 : 55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:NVRO	Nevro Corp
2024/02/29	06 : 10	PR Newswire (US)	Nevro Receives FDA 510(k) Clearance to Use SI Fixation System Without Need to Include Lateral Screw	NYSE:NVRO	Nevro Corp
2024/02/24	07 : 08	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NYSE:NVRO	Nevro Corp
2024/02/23	06 : 19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:NVRO	Nevro Corp
2024/02/23	06 : 16	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NYSE:NVRO	Nevro Corp